{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:07:26Z","timestamp":1789697246045,"version":"4.0.1"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Extended Spectrum Beta Lactamase (ESBL) production in gram negative\nbacteria confers multiple antibiotic resistance, adversely affecting antimicrobial therapy in infected\nindividuals. ESBLs result from mutations in \u03b2-lactamases encoded mainly by the bla<jats:sub>TEM<\/jats:sub>,bla<jats:sub>SHV<\/jats:sub> and\nbla<jats:sub>CTX-M<\/jats:sub> genes. The prevalence of ESBL producing bacteria has been on the increase globally, especially\nits upsurge among isolates from community-acquired infections has been observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>To determine ESBL prevalence and identify ESBL genes among clinical isolates in Osun\nState, Nigeria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Material and Methods:<\/jats:title>\n<jats:p>A cross-sectional study was carried out from August 2016 \u2013 July 2017 in\nOsun State, Nigeria. Three hundred and sixty Gram-negative bacteria recovered from clinical samples\nobtained from both community and healthcare-associated infections were tested. They included\n147 Escherichia coli (40.8%), 116 Klebsiella spp (32.2%), 44 Pseudomonas aeruginosa\n(12.2%) and 23 Proteus vulgaris (6.4%) isolates. Others were Acinetobacter baumannii, Serratia\nrubidae, Citrobacter spp, Enterobacter spp and Salmonella typhi. Disk diffusion antibiotic susceptibility\ntesting was carried out, isolates were screened for ESBL production and confirmed using\nstandard laboratory procedures. ESBLs resistance genes were identified by Polymerase Chain\nReaction (PCR).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>All isolates demonstrated multiple antibiotic resistance. Resistance to ampicillin, amoxicillin\nwith clavulanate and erythromycin was 100%, whereas resistance to Imipenem was very low\n(5.0%).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The overall prevalence of ESBL producers was 41.4% with Klebsiella spp as the highest ESBL producing\nEnterobacteriacaea. ESBL producers were more prevalent among the hospital pathogens\nthan community pathogens, 58% vs. 29.5% (p=0.003). ESBL genes were detected in all ESBL producers\nwith the bla<jats:sub>CTX-M<\/jats:sub> gene predominating (47.0%) followed by bla<jats:sub>TEM<\/jats:sub> (30.9%) and bla<jats:sub>SHV<\/jats:sub> gene\nwas the least, 22.1%. The bla<jats:sub>CTX-M<\/jats:sub> gene was also the most prevalent in the healthcare pathogens\n(62%) but it accounted for only 25% in those of community origin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>A high prevalence of ESBL producing gram-negative organisms occurs both in healthcare\nand in the community in our environment with the CTX-M variant predominating. Efforts to\ncontrol the spread of these pathogens should be addressed.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526520999200729181559","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T11:11:36Z","timestamp":1596107496000},"page":"595-602","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Extended Spectrum Beta Lactamase (ESBL), blaTEM,blaSHV and blaCTX-M, Resistance Genes in Community and Healthcare Associated Gram Negative Bacteria from Osun State, Nigeria"],"prefix":"10.2174","volume":"21","author":[{"given":"Ganiyat","family":"Shitta","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Ogbomosho,Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-0183","authenticated-orcid":true,"given":"Olufunmilola","family":"Makanjuola","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, University of Ibadan, Oyo,Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusolabomi","family":"Adefioye","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Ogbomosho,Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olugbenga Adekunle","family":"Olowe","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Ogbomosho,Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"O20","DOI":"10.1111\/1469-0691.12321","volume":"20","author":"Gibold L.","year":"2014","unstructured":"Gibold L.; Robin F.; Tan R-N.; Delmas J.; Bonnet R.; Four-year epidemiological study of extended-spectrum &#x3B2;-lactamase-producing Enterobacteriaceae in a French teaching hospital. Clin Microbiol Infect 2014,20(1),O20-O26","journal-title":"Clin Microbiol Infect"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"Bradford P.A.","year":"2001","unstructured":"Bradford P.A.; Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001,14(4),933-951","journal-title":"Clin Microbiol Rev"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/mdr.2009.0132","volume":"16","author":"Smet A.","year":"2010","unstructured":"Smet A.; Martel A.; Persoons D.; Dewulf J.; Heyndrickx M.; Claeys G.; Lontie M.; Van Meensel B.; Herman L.; Haesebrouck F.; Butaye P.; Characterization of extended-spectrum &#x3B2;-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010,16(2),129-134","journal-title":"Microb Drug Resist"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"Paterson D.L.","year":"2005","unstructured":"Paterson D.L.; Bonomo R.A.; Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005,18(4),657-686","journal-title":"Clin Microbiol Rev"},{"key":"ref=5","first-page":"393","volume":"49","author":"Giedraitien\u0117 A.","year":"2013","unstructured":"Giedraitien\u0117 A.; Vitkauskien\u0117 A.; A\u0161monien\u0117 V.; Plan&#x10D;i&#x16B;nien\u0117 R.; Simonyt\u0117 S.; Pavilonis A.; Arlet G.; CTX-M-producing Escherichia coli in Lithuania: associations between sites of infection, coresistance, and phylogenetic groups. Medicina (Kaunas) 2013,49(9),393-398","journal-title":"Medicina (Kaunas)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejmhg.2013.05.002","volume":"14","author":"Ahmed O.I.","year":"2013","unstructured":"Ahmed O.I.; El-Hady S.A.; Ahmed T.M.; Ahmed I.Z.; Detection of bla SHV and bla CTX-M genes in ESBL producing Klebsiella pneumoniae isolated from Egyptian patients with suspected nosocomial infections. Egypt J Med Hum Genet 2013,14(3),277-283","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/14656566.2013.763030","volume":"14","author":"Lynch J.P.","year":"2013","unstructured":"Lynch J.P.; Clark N.M.; Zhanel G.G.; Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum &#x3B2;-lactamases and carbapenemases). Expert Opin Pharmacother 2013,14(2),199-210","journal-title":"Expert Opin Pharmacother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/jac\/dkq482","volume":"66","author":"Xu L.","year":"2011","unstructured":"Xu L.; Shabir S.; Bodah T.; McMurray C.; Hardy K.; Hawkey P.; Nye K.; Regional survey of CTX-M-type extended-spectrum &#x3B2;-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone. J Antimicrob Chemother 2011,66(3),505-511","journal-title":"J Antimicrob Chemother"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1128\/AAC.00745-12","volume":"56","author":"Sennati S.","year":"2012","unstructured":"Sennati S.; Santella G.; Di Conza J.; Pallecchi L.; Pino M.; Ghiglione B.; Rossolini G.M.; Radice M.; Gutkind G.; Changing epidemiology of extended-spectrum &#x3B2;-lactamases in Argentina: emergence of CTX-M-15. Antimicrob Agents Chemother 2012,56(11),6003-6005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3201\/eid1311.070674","volume":"13","author":"Okeke I.N.","year":"2007","unstructured":"Okeke I.N.; Aboderin O.A.; Byarugaba D.K.; Ojo K.K.; Opintan J.A.; Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 2007,13(11),1640-1646","journal-title":"Emerg Infect Dis"},{"key":"ref=11","year":"2014","unstructured":"Antimicrobial resistance Global Report on Surveillance World Health Organization2014","journal-title":"Antimicrobial resistance Global Report on Surveillance"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ijantimicag.2017.07.002","volume":"50","author":"Bernab&#xE9; K.J.","year":"2017","unstructured":"Bernab&#xE9; K.J.; Langendorf C.; Ford N.; Ronat J.B.; Murphy R.A.; Antimicrobial resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents 2017,50(5),629-639","journal-title":"Int J Antimicrob Agents"},{"key":"ref=13","year":"2017","unstructured":"Antimicrobial Use and Resistance in Nigeria- Situation analysis and recommendation Federal Ministries of Agriculture Environment and Health N2017","journal-title":"Antimicrobial Use and Resistance in Nigeria- Situation analysis and recommendation"},{"key":"ref=14","first-page":"327","volume":"5","author":"Okesola A.O.","year":"2009","unstructured":"Okesola A.O.; Oni A.A.; Antimicrobial Resistance Among Common Bacterial Pathogens in South Western Nigeria. J Agric Environ Sci 2009,5(3),327-330","journal-title":"J Agric Environ Sci"},{"key":"ref=15","author":"Cowan S.","year":"2003","unstructured":"Cowan S.;  2003"},{"key":"ref=16","year":"2016","unstructured":"Performance standards for antimicrobial susceptibility testing; Twenty-sixth informational supplement CLSI document M100-S26 Clinical and Laboratory Standards Institute (CLSI)2016","journal-title":"Performance standards for antimicrobial susceptibility testing; Twenty-sixth informational supplement CLSI document M100-S26"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","volume":"14","author":"Drieux L.","year":"2008","unstructured":"Drieux L.; Brossier F.; Sougakoff W.; Jarlier V.; Phenotypic detection of extended-spectrum &#x3B2;-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008,14(Suppl. 1),90-103","journal-title":"Clin Microbiol Infect"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1469-0691.2007.01869.x","volume":"14","author":"Villegas M.V.","year":"2008","unstructured":"Villegas M.V.; Kattan J.N.; Quinteros M.G.; Casellas J.M.; Prevalence of extended-spectrum &#x3B2;-lactamases in South America. Clin Microbiol Infect 2008,14(Suppl. 1),154-158","journal-title":"Clin Microbiol Infect"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13756-018-0309-1","volume":"7","author":"Abrar S.","year":"2018","unstructured":"Abrar S.; Hussain S.; Khan R.A.; Ul Ain N.; Haider H.; Riaz S.; Prevalence of extended-spectrum-&#x3B2;-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrob Resist Infect Control 2018,7(1),26","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1128\/AAC.00666-12","volume":"56","author":"Chandramohan L.","year":"2012","unstructured":"Chandramohan L.; Revell P.A.; Prevalence and molecular characterization of extended-spectrum-&#x3B2;-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob Agents Chemother 2012,56(9),4765-4770","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.7860\/JCDR\/2013\/6460.3462","volume":"7","author":"Sharma M.","year":"2013","unstructured":"Sharma M.; Pathak S.; Srivastava P.; Prevalence and antibiogram of Extended Spectrum &#x3B2;-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 2013,7(10),2173-2177","journal-title":"J Clin Diagn Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/mdr.2009.0096","volume":"16","author":"Feizabadi M.M.","year":"2010","unstructured":"Feizabadi M.M.; Delfani S.; Raji N.; Majnooni A.; Aligholi M.; Shahcheraghi F.; Parvin M.; Yadegarinia D.; Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist 2010,16(1),49-53","journal-title":"Microb Drug Resist"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4314\/ajcem.v14i2.12","volume":"14","author":"Yusuf I.","year":"2013","unstructured":"Yusuf I.; Haruna M.; Yahaya H.; Prevalence and antibiotic susceptibility of AmpC and ESBLs producing clinical isolates at a tertiary health care center in Kano, north-west Nigeria. Afr J Clin Exp Microbiol 2013,14(2),109-119","journal-title":"Afr J Clin Exp Microbiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.medmal.2014.07.006","volume":"44","author":"Zahar J.R.","year":"2014","unstructured":"Zahar J.R.; Lesprit P.; Management of multidrug resistant bacterial endemic. Med Mal Infect 2014,44(9),405-411","journal-title":"Med Mal Infect"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"12043","DOI":"10.4238\/2015.October.5.17","volume":"14","author":"Huang S.Y.","year":"2015","unstructured":"Huang S.Y.; Pan K.Y.; Liu X.Q.; Xie X.Y.; Dai X.L.; Chen B.J.; Wu X.Q.; Li H.Y.; Analysis of the drug-resistant characteristics of Klebsiella pneumoniae isolated from the respiratory tract and CTX-M ESBL genes. Genet Mol Res 2015,14(4),12043-12048","journal-title":"Genet Mol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/ice.2017.156","volume":"38","author":"McDanel J.","year":"2017","unstructured":"McDanel J.; Schweizer M.; Crabb V.; Nelson R.; Samore M.; Khader K.; Blevins A.E.; Diekema D.; Chiang H.Y.; Nair R.; Perencevich E.; Incidence of extended-spectrum &#x3B2;-lactamase (esbl)-producing escherichia coli and klebsiella infections in the united states: a systematic literature review. Infect Control Hosp Epidemiol 2017,38(10),1209-1215","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12941-016-0144-2","volume":"15","author":"Oduro-Mensah D.","year":"2016","unstructured":"Oduro-Mensah D.; Obeng-Nkrumah N.; Bonney E.Y.; Oduro-Mensah E.; Twum-Danso K.; Osei Y.D.; Sackey S.T.; Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana. Ann Clin Microbiol Antimicrob 2016,15(1),29","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=28","first-page":"138","volume":"15","author":"Wollheim C.","year":"2011","unstructured":"Wollheim C.; Guerra I.M.F.; Conte V.D.; Hoffman S.P.; Schreiner F.J.; Delamare A.P.L.; Barth A.L.; Echeverrigaray S.; Costa S.O.; Nosocomial and community infections due to class A extended-spectrum &#x3B2;-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis 2011,15(2),138-143","journal-title":"Braz J Infect Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/1658-600X.179829","volume":"4","author":"Al Mously N.","year":"2016","unstructured":"Al Mously N.; Al Arfaj O.; Al Fadhil L.; Mukaddam S.; Antimicrobial susceptibility patterns of ESBL Escherichia coli isolated from community and hospital-acquired urinary tract infections. J Heal Spec 2016,4(2),133","journal-title":"J Heal Spec"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.00026-07","volume":"51","author":"Pallecchi L.","year":"2007","unstructured":"Pallecchi L.; Bartoloni A.; Fiorelli C.; Mantella A.; Di Maggio T.; Gamboa H.; Gotuzzo E.; Kronvall G.; Paradisi F.; Rossolini G.M.; Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007,51(8),2720-2725","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108735","volume":"9","author":"Lina T.T.","year":"2014","unstructured":"Lina T.T.; Khajanchi B.K.; Azmi I.J.; Islam M.A.; Mahmood B.; Akter M.; Banik A.; Alim R.; Navarro A.; Perez G.; Cravioto A.; Talukder K.A.; Phenotypic and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli in Bangladesh. PLoS One 2014,9(10)","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/jac\/dkr523","volume":"67","author":"Khanna N.","year":"2012","unstructured":"Khanna N.; Boyes J.; Lansdell P.M.; Hamouda A.; Amyes S.G.B.; Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-&#x3B2;-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 2012,67(3),573-577","journal-title":"J Antimicrob Chemother"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1179\/1973947813Y.0000000148","volume":"26","author":"Dias V.C.","year":"2014","unstructured":"Dias V.C.; da Silva V.L.; Barros R.; Bastos A.N.; de Andrade Bastos L.Q.; de Andrade Bastos V.Q.; Diniz C.G.; Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections. J Chemother 2014,26(6),328-332","journal-title":"J Chemother"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184341","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184341\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:13:54Z","timestamp":1648721634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184341\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526520999200729181559","relation":{},"ISSN":["1871-5265"],"issn-type":[{"value":"1871-5265","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}